| Product Code: ETC8545662 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Netherlands Personalized Cancer Vaccines Market Overview |
3.1 Netherlands Country Macro Economic Indicators |
3.2 Netherlands Personalized Cancer Vaccines Market Revenues & Volume, 2021 & 2031F |
3.3 Netherlands Personalized Cancer Vaccines Market - Industry Life Cycle |
3.4 Netherlands Personalized Cancer Vaccines Market - Porter's Five Forces |
3.5 Netherlands Personalized Cancer Vaccines Market Revenues & Volume Share, By Cancer Type, 2021 & 2031F |
3.6 Netherlands Personalized Cancer Vaccines Market Revenues & Volume Share, By Mechanism of Action Type, 2021 & 2031F |
3.7 Netherlands Personalized Cancer Vaccines Market Revenues & Volume Share, By Technology, 2021 & 2031F |
3.8 Netherlands Personalized Cancer Vaccines Market Revenues & Volume Share, By Bio-Maker Type, 2021 & 2031F |
3.9 Netherlands Personalized Cancer Vaccines Market Revenues & Volume Share, By Treatment Type, 2021 & 2031F |
3.10 Netherlands Personalized Cancer Vaccines Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.11 Netherlands Personalized Cancer Vaccines Market Revenues & Volume Share, By End Users, 2021 & 2031F |
4 Netherlands Personalized Cancer Vaccines Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of cancer in the Netherlands |
4.2.2 Growing awareness about personalized medicine and its benefits |
4.2.3 Technological advancements in cancer treatment and vaccine development |
4.3 Market Restraints |
4.3.1 Stringent regulations and high costs associated with personalized cancer vaccines |
4.3.2 Limited availability of skilled professionals in the field of personalized medicine |
5 Netherlands Personalized Cancer Vaccines Market Trends |
6 Netherlands Personalized Cancer Vaccines Market, By Types |
6.1 Netherlands Personalized Cancer Vaccines Market, By Cancer Type |
6.1.1 Overview and Analysis |
6.1.2 Netherlands Personalized Cancer Vaccines Market Revenues & Volume, By Cancer Type, 2021- 2031F |
6.1.3 Netherlands Personalized Cancer Vaccines Market Revenues & Volume, By Lung Cancer, 2021- 2031F |
6.1.4 Netherlands Personalized Cancer Vaccines Market Revenues & Volume, By Breast Cancer, 2021- 2031F |
6.1.5 Netherlands Personalized Cancer Vaccines Market Revenues & Volume, By Colorectal Cancer, 2021- 2031F |
6.1.6 Netherlands Personalized Cancer Vaccines Market Revenues & Volume, By Leukaemia, 2021- 2031F |
6.1.7 Netherlands Personalized Cancer Vaccines Market Revenues & Volume, By Prostate Cancer, 2021- 2031F |
6.1.8 Netherlands Personalized Cancer Vaccines Market Revenues & Volume, By Cervical Cancer, 2021- 2031F |
6.2 Netherlands Personalized Cancer Vaccines Market, By Mechanism of Action Type |
6.2.1 Overview and Analysis |
6.2.2 Netherlands Personalized Cancer Vaccines Market Revenues & Volume, By Tumour-associated Antigens (TAAs), 2021- 2031F |
6.2.3 Netherlands Personalized Cancer Vaccines Market Revenues & Volume, By Tumour-specific Antigens (TSAs), 2021- 2031F |
6.2.4 Netherlands Personalized Cancer Vaccines Market Revenues & Volume, By Somatic Mutations in Cancer Pharmacogenomics, 2021- 2031F |
6.2.5 Netherlands Personalized Cancer Vaccines Market Revenues & Volume, By Pharmacogenomics towards Genomic Polymorphism, 2021- 2031F |
6.3 Netherlands Personalized Cancer Vaccines Market, By Technology |
6.3.1 Overview and Analysis |
6.3.2 Netherlands Personalized Cancer Vaccines Market Revenues & Volume, By Dendritic Cells (DC) Cancer Vaccines, 2021- 2031F |
6.3.3 Netherlands Personalized Cancer Vaccines Market Revenues & Volume, By Recombinant Cancer Vaccines, 2021- 2031F |
6.3.4 Netherlands Personalized Cancer Vaccines Market Revenues & Volume, By Antigen/Adjuvant Cancer Vaccines, 2021- 2031F |
6.3.5 Netherlands Personalized Cancer Vaccines Market Revenues & Volume, By Viral Vector and DNA Cancer Vaccines, 2021- 2031F |
6.4 Netherlands Personalized Cancer Vaccines Market, By Bio-Maker Type |
6.4.1 Overview and Analysis |
6.4.2 Netherlands Personalized Cancer Vaccines Market Revenues & Volume, By Pharmacogenomics, 2021- 2031F |
6.4.3 Netherlands Personalized Cancer Vaccines Market Revenues & Volume, By Prognostic and Predictive Biomarkers, 2021- 2031F |
6.4.4 Netherlands Personalized Cancer Vaccines Market Revenues & Volume, By Immune Checkpoint Biomarkers, 2021- 2031F |
6.4.5 Netherlands Personalized Cancer Vaccines Market Revenues & Volume, By Others, 2021- 2031F |
6.5 Netherlands Personalized Cancer Vaccines Market, By Treatment Type |
6.5.1 Overview and Analysis |
6.5.2 Netherlands Personalized Cancer Vaccines Market Revenues & Volume, By Preventive Cancer Vaccines, 2021- 2031F |
6.5.3 Netherlands Personalized Cancer Vaccines Market Revenues & Volume, By Therapeutic Cancer Vaccines, 2021- 2031F |
6.6 Netherlands Personalized Cancer Vaccines Market, By Route of Administration |
6.6.1 Overview and Analysis |
6.6.2 Netherlands Personalized Cancer Vaccines Market Revenues & Volume, By Injectables, 2021- 2031F |
6.6.3 Netherlands Personalized Cancer Vaccines Market Revenues & Volume, By Others, 2021- 2031F |
6.7 Netherlands Personalized Cancer Vaccines Market, By End Users |
6.7.1 Overview and Analysis |
6.7.2 Netherlands Personalized Cancer Vaccines Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.7.3 Netherlands Personalized Cancer Vaccines Market Revenues & Volume, By Homecare, 2021- 2031F |
6.7.4 Netherlands Personalized Cancer Vaccines Market Revenues & Volume, By Others, 2021- 2031F |
6.7.5 Netherlands Personalized Cancer Vaccines Market Revenues & Volume, By Others, 2021- 2031F |
7 Netherlands Personalized Cancer Vaccines Market Import-Export Trade Statistics |
7.1 Netherlands Personalized Cancer Vaccines Market Export to Major Countries |
7.2 Netherlands Personalized Cancer Vaccines Market Imports from Major Countries |
8 Netherlands Personalized Cancer Vaccines Market Key Performance Indicators |
8.1 Patient survival rates post-administration of personalized cancer vaccines |
8.2 Number of clinical trials and research studies focused on personalized cancer vaccines in the Netherlands |
8.3 Adoption rate of personalized cancer vaccines among healthcare providers and patients |
9 Netherlands Personalized Cancer Vaccines Market - Opportunity Assessment |
9.1 Netherlands Personalized Cancer Vaccines Market Opportunity Assessment, By Cancer Type, 2021 & 2031F |
9.2 Netherlands Personalized Cancer Vaccines Market Opportunity Assessment, By Mechanism of Action Type, 2021 & 2031F |
9.3 Netherlands Personalized Cancer Vaccines Market Opportunity Assessment, By Technology, 2021 & 2031F |
9.4 Netherlands Personalized Cancer Vaccines Market Opportunity Assessment, By Bio-Maker Type, 2021 & 2031F |
9.5 Netherlands Personalized Cancer Vaccines Market Opportunity Assessment, By Treatment Type, 2021 & 2031F |
9.6 Netherlands Personalized Cancer Vaccines Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.7 Netherlands Personalized Cancer Vaccines Market Opportunity Assessment, By End Users, 2021 & 2031F |
10 Netherlands Personalized Cancer Vaccines Market - Competitive Landscape |
10.1 Netherlands Personalized Cancer Vaccines Market Revenue Share, By Companies, 2024 |
10.2 Netherlands Personalized Cancer Vaccines Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here